Timasheva, Yu.,
Zudina, L.,
Balkhiyarova, Zh.,
Kaakinen, M.,
Munroe, P.,
Prokopenko, I. (2019) Pembrolizumab monotherapy for the
adjuvant treatment of renal cell carcinoma post
of PC, response to
chemotherapy and development of
postoperative metastasis.
Yunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) recommendations. Altogether, 369 patients completed the full course of
chemotherapy. Clinical characteristics